2026-04-29T04:10:02Zhttps://repisalud.isciii.es/rest/oai/request
oai:repisalud.isciii.es:20.500.12105/185902024-09-21T20:31:28Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16927
Repisalud author Duran, Ivan author Zieba, Jennifer author Csukasi, Fabiana author Martin, Jorge H author Wachtell, Davis author Barad, Maya author Dawson, Brian author Fafilek, Bohumil author Jacobsen, Christina M author Ambrose, Catherine G author Cohn, Daniel H author Krejci, Pavel author Lee, Brendan H author Krakow, Deborah 2024-02-27T14:57:59Z 2024-02-27T14:57:59Z 2022-01-28 http://hdl.handle.net/10668/22150 http://hdl.handle.net/20.500.12105/18590 34997935 10.1002/jbmr.4501 1523-4681 Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research Osteogenesis imperfecta (OI) is a genetically heterogenous disorder most often due to heterozygosity for mutations in the type I procollagen genes, COL1A1 or COL1A2. The disorder is characterized by bone fragility leading to increased fracture incidence and long-bone deformities. Although multiple mechanisms underlie OI, endoplasmic reticulum (ER) stress as a cellular response to defective collagen trafficking is emerging as a contributor to OI pathogenesis. Herein, we used 4-phenylbutiric acid (4-PBA), an established chemical chaperone, to determine if treatment of Aga2+/- mice, a model for moderately severe OI due to a Col1a1 structural mutation, could attenuate the phenotype. In vitro, Aga2+/- osteoblasts show increased protein kinase RNA-like endoplasmic reticulum kinase (PERK) activation protein levels, which improved upon treatment with 4-PBA. The in vivo data demonstrate that a postweaning 5-week 4-PBA treatment increased total body length and weight, decreased fracture incidence, increased femoral bone volume fraction (BV/TV), and increased cortical thickness. These findings were associated with in vivo evidence of decreased bone-derived protein levels of the ER stress markers binding immunoglobulin protein (BiP), CCAAT/-enhancer-binding protein homologous protein (CHOP), and activating transcription factor 4 (ATF4) as well as increased levels of the autophagosome marker light chain 3A/B (LC3A/B). Genetic ablation of CHOP in Aga2+/- mice resulted in increased severity of the Aga2+/- phenotype, suggesting that the reduction in CHOP observed in vitro after treatment is a consequence rather than a cause of reduced ER stress. These findings suggest the potential use of chemical chaperones as an adjunct treatment for forms of OI associated with ER stress. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). eng 4-PBA Aga2 Bip+/− Chop−/− ER stress bone osteogenesis imperfecta 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta. research article